Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.
Changzhou Qianhong Biopharma Dividend Announcement
• Changzhou Qianhong Biopharma announced a annually dividend of ¥0.12 per ordinary share which will be made payable on 2024-05-29. Ex dividend date: 2024-05-29
• Changzhou Qianhong Biopharma annual dividend for 2024 was ¥0.12
• Changzhou Qianhong Biopharma annual dividend for 2023 was ¥0.12
• Changzhou Qianhong Biopharma's trailing twelve-month (TTM) dividend yield is 1.95%
• Changzhou Qianhong Biopharma's payout ratio for the trailing twelve months (TTM) is 51.74%
• Changzhou Qianhong Biopharma's dividend growth over the last five years (2018-2023) was 8.45% year
• Changzhou Qianhong Biopharma's dividend growth over the last ten years (2013-2023) was -13.30% year
Changzhou Qianhong Biopharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-29 | ¥0.12 | annually | 2024-05-29 |
2023-05-26 | ¥0.12 | annually | 2023-05-26 |
2022-05-25 | ¥0.12 | annually | 2022-05-25 |
2021-05-21 | ¥0.12 | annually | 2021-05-21 |
2020-05-27 | ¥0.25 | annually | 2020-05-27 |
2019-05-28 | ¥0.12 | annually | 2019-05-28 |
2018-06-21 | ¥0.08 | annually | 2018-06-21 |
2017-06-01 | ¥0.08 | annually | 2017-06-01 |
2016-05-31 | ¥0.30 | annually | |
2015-05-26 | ¥0.30 | annually | |
2014-04-18 | ¥0.50 | annually | |
2013-05-17 | ¥0.50 | annually |
Changzhou Qianhong Biopharma Dividend per year
Changzhou Qianhong Biopharma Dividend growth
Changzhou Qianhong Biopharma Dividend Yield
Changzhou Qianhong Biopharma current trailing twelve-month (TTM) dividend yield is 1.95%. Interested in purchasing Changzhou Qianhong Biopharma stock? Use our calculator to estimate your expected dividend yield:
Changzhou Qianhong Biopharma Financial Ratios
Changzhou Qianhong Biopharma Dividend FAQ
Other factors to consider when evaluating Changzhou Qianhong Biopharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Changzhou Qianhong Biopharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Changzhou Qianhong Biopharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Changzhou Qianhong Biopharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Changzhou Qianhong Biopharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Changzhou Qianhong Biopharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Changzhou Qianhong Biopharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Changzhou Qianhong Biopharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Changzhou Qianhong Biopharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Changzhou Qianhong Biopharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Changzhou Qianhong Biopharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.